IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Advances in Cancer Research

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

3.74

h-Index

2024-2025

 113

Rank

2024-2025

 9648

SJR

2024-2025

 0.601

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Advances in Cancer Research
Abbreviation Adv. Cancer Res.
Publication Type Book series
Subject Area, Categories, Scope Cancer Research (Q3); Oncology (Q3)
h-index 113
Overall Rank/Ranking 9648
SCImago Journal Rank (SJR) 0.601
Impact Score 3.74
Publisher Academic Press Inc.
Country United States
ISSN 21625557, 0065230X
Best Quartile Q3
Coverage History 1953-1956, 1958, 1962-1965, 1967, 1969-2024




About Advances in Cancer Research


Advances in Cancer Research is a book series covering the technologies/fields/categories related to Cancer Research (Q3); Oncology (Q3). It is published by Academic Press Inc.. The overall rank of Advances in Cancer Research is 9648. According to SCImago Journal Rank (SJR), this book series is ranked 0.601. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This book series has an h-index of 113. The best quartile for this book series is Q3.

The ISSN of Advances in Cancer Research book series is 21625557, 0065230X. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Advances in Cancer Research is cited by a total of 858 articles during the last 3 years (Preceding 2024).


Advances in Cancer Research Impact IF 2024-2025


The Impact IF 2024 of Advances in Cancer Research is 3.74, which is computed in 2025 as per its definition. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting


Impact IF Trend


Year wise Impact IF of Advances in Cancer Research. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 3.74
2023 6.60
2021 5.39
2020 5.92
2019 5.08
2018 4.54
2017 6.26
2016 6.23
2015 5.19
2014 5.18

Advances in Cancer Research h-index


  Table Setting

Advances in Cancer Research has an h-index of 113. It means 113 articles of this book series have more than 113 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Advances in Cancer Research ISSN


The ISSN of Advances in Cancer Research is 21625557, 0065230X. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Advances in Cancer Research Rank and SCImago Journal Rank (SJR)


The overall rank of Advances in Cancer Research is 9648. According to SCImago Journal Rank (SJR), this book series is ranked 0.601. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Advances in Cancer Research by Year


Year SJR
2025/2026 Coming Soon
2024 0.601
2023
2021 1.651
2020 1.570
2019 0.893
2018
2017 3.043
2016 2.389
2015 2.222
2014 2.683

Ranking of Advances in Cancer Research by Year


Year Ranking
2025/2026 Coming Soon
2024 9648
2023 28962
2021 1788
2020 2091
2019 5117
2018 31587
2017 639
2016 1005
2015 1192
2014 815

Advances in Cancer Research Publisher


Table Setting

Advances in Cancer Research is published by Academic Press Inc.. It's publishing house is located in United States. Coverage history of this book series is as following: 1953-1956, 1958, 1962-1965, 1967, 1969-2024. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Advances in Cancer Research is Adv. Cancer Res.. This abbreviation ('Adv. Cancer Res.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Advances in Cancer Research


If your research field is/are related to Cancer Research (Q3); Oncology (Q3), then please visit the official website of this book series.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Advances in Cancer Research?

Advances in Cancer Research latest impact IF is 3.74. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this book series are 6.60 (2023) and 3.74 (2024), respectively, in the last 10 years. Moreover, its average IS is 5.41 in the previous 10 years.


What's the SCImago Journal Rank (SJR) of the Advances in Cancer Research?

The Advances in Cancer Research has an SJR (SCImago Journal Rank) of 0.601, according to the latest data. It is computed in the year 2025. In the past 10 years, this book series has recorded a range of SJR, with the highest being 3.043 in 2017 and the lowest being in 2023. Furthermore, the average SJR of the Advances in Cancer Research over the previous 10-year period stands at 5.41.


What's the latest h-index of the Advances in Cancer Research?

The latest h-index of the Advances in Cancer Research is 113.


Who's the publisher of the Advances in Cancer Research?

The Advances in Cancer Research is published by the Academic Press Inc., with its country of publication being the United States.


What's the current ranking of the Advances in Cancer Research?

The Advances in Cancer Research is currently ranked 9648 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this book series has experienced varying rankings, reaching its highest position of 639 in 2017 and its lowest position of 31587 in 2018.


What's the abbreviation or short name for the Advances in Cancer Research?

The standard ISO4 abbreviation for the Advances in Cancer Research is Adv. Cancer Res..


Is the "Advances in Cancer Research" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Advances in Cancer Research is classified as a book series that the Academic Press Inc. publishes.


What's the scope or major areas of the Advances in Cancer Research?

The Advances in Cancer Research encompasses the following areas:

  • Cancer Research
  • Oncology

For a more comprehensive understanding of its scope, check the official website of this book series.


What's the ISSN of the Advances in Cancer Research?

The Advances in Cancer Research is assigned the following International Standard Serial Numbers (ISSN): 21625557, 0065230X.


What's the best quartile of the Advances in Cancer Research?

The best quartile for the Advances in Cancer Research is Q3 (2024).


What's the coverage history of the Advances in Cancer Research?

The Advances in Cancer Research coverage history can be summarized as follows: 1953-1956, 1958, 1962-1965, 1967, 1969-2024.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Zeitschrift fur Germanistische Linguistik journal 27452 Walter de Gruyter GmbH 17 0.29
Historia journal 22470 Universidade Estadual Paulista 9 0.16
Applied Ecology and Environmental Research journal 19122 Corvinus University of Budapest 48 0.84
Sex Education journal 6348 Routledge 51 2.49
Howard Journal of Communications journal 14582 Taylor and Francis Ltd. 42 1.27
Studies in Continuing Education journal 4850 Routledge 44 3.35
Proceedings of the International Semiconductor Conference, CAS conference and proceedings 25734 Institute of Electrical and Electronics Engineers Inc. 16 0.00
Consulting engineer Barrington journal 24079 Cahners Pub. Co. 0 0.00
European Journal of Wildlife Research journal 10254 Springer Verlag 62 1.99
Rudarsko Geolosko Naftni Zbornik journal 14286 Faculty of Mining, Geology and Petroleum Engineering University of Zagreb 22 1.78

Check complete list




Year wise Impact Score (IS) of Advances in Cancer Research

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 3.74
2023 6.60
2021 5.39
2020 5.92
2019 5.08
2018 4.54
2017 6.26
2016 6.23
2015 5.19
2014 5.18



Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Nature Cancer
Nature Research | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins | United States

Journal of Hematology and Oncology
BioMed Central Ltd | United Kingdom

Molecular Cancer
BioMed Central Ltd | United Kingdom

JAMA Oncology
American Medical Association | United States

Cell Host and Microbe
Cell Press | United States

Neuro-Oncology
Oxford University Press | United Kingdom

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
John Wiley and Sons Inc | United States

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Annals of Oncology
Elsevier Ltd | United Kingdom

Cancer Cell
Cell Press | United States

Nature Cancer
Nature Research | United States

Lancet Oncology, The
Elsevier Ltd | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins | United States

Journal of Hematology and Oncology
BioMed Central Ltd | United Kingdom

Molecular Cancer
BioMed Central Ltd | United Kingdom

See All